Market Tracker

08/22 5:16pm ET

Abiomed Inc (NASDAQ:ABMD)

154.99
Delayed Data
As of 4:00pm ET
 +1.67 / +1.09%
Today’s Change
95.14
Today|||52-Week Range
157.41
+37.55%
Year-to-Date
Closing the Door on Abiomed
Aug 16 / TheStreet.com - Paid Partner Content
Why ABIOMED (ABMD) Could Be Positioned for a Surge
Aug 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close153.32
Today’s open153.00
Day’s range152.64 - 155.59
Volume281,986
Average volume (3 months)307,926
Market cap$6.8B
Dividend yield--
Data as of 4:00pm ET, 08/22/2017

Growth & Valuation

Earnings growth (last year)+37.65%
Earnings growth (this year)+84.81%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)+35.13%
P/E ratio91.2
Price/Sales12.56
Price/Book14.81

Competitors

 Today’s
change
Today’s
% change
DXCMDexCom Inc+2.85+3.90%
WSTWest Pharmaceutical ...+0.59+0.69%
MASIMasimo Corp+0.25+0.29%
TFXTeleflex Inc+1.23+0.58%
Data as of 4:02pm ET, 08/22/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$0.38
Annual revenue (last year)$445.3M
Annual profit (last year)$52.1M
Net profit margin11.70%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts